Complete Dose Range Despite Market Price Pressures
Wegovy Price Increase Reality: How EverydayMeds Maintains Full Stock
The recent wegovy price increase has created significant supply chain pressures, with many pharmacies struggling to maintain consistent stock across all five dose strengths. EverydayMeds has prioritised securing reliable supplies of every Wegovy dose, recognising that patients cannot safely skip or substitute doses during their escalation schedule. Our approach ensures continuity of care despite market volatility. While the wegovy price increase has affected our wholesale costs, we've absorbed much of this impact through efficient operations and bulk purchasing agreements with Novo Nordisk.
This commitment means patients starting their Wegovy journey can remain with the same trusted pharmacy throughout their entire treatment. The 20-week dose escalation protocol requires precise progression from 0.25mg through to 2.4mg maintenance, making pharmacy consistency crucial for treatment success. Our comprehensive stock holding eliminates the common problem of patients having to source different doses from multiple pharmacies, each with varying pricing structures and service standards.
Current Wegovy Price Increase Impact on UK Market Pricing
Despite the wegovy price increase affecting wholesale costs, EverydayMeds maintains competitive pricing across all dose strengths. Single pens range from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance dose. New customers receive code FIRST40 at checkout, while returning patients benefit from DOSE25 on subsequent orders. These discount codes are applied during the checkout process to reach our published prices.
Our bundle options provide additional value and convenience, particularly our Getting Started Bundles that combine consecutive doses. The Intro Duo (0.25mg and 0.5mg) costs £169.99, covering your first 8 weeks of treatment. For patients concerned about supply security following the wegovy price increase, our 3-pen Ultimate Stability Trio provides three months of maintenance 2.4mg doses for £649.99, ensuring uninterrupted treatment continuation.
Clinical Evidence Supporting Wegovy Despite Price Increase Concerns
The wegovy price increase shouldn't deter patients from accessing this clinically proven treatment. In the landmark STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved an average clinically studied weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained 15.2% weight reduction maintained at two years with continued treatment.
Recent SELECT cardiovascular outcomes data showed a 20% reduction in major cardiovascular events (HR 0.80) in patients with established cardiovascular disease. These robust clinical outcomes demonstrate that Wegovy represents significant value for money, even considering the wegovy price increase, when viewed against long-term health benefits and potential healthcare cost savings.
Understanding How Wegovy Works Beyond Price Considerations
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural hormones controlling appetite and food intake. This prescription-only medicine works on brain centres responsible for hunger signals, helping patients feel fuller after smaller meals and reducing food cravings between meals. The once-weekly injection delivers consistent medication levels, providing 24/7 appetite regulation support. Clinical studies demonstrate that Wegovy may help patients achieve meaningful weight loss when combined with reduced-calorie diet and increased physical activity. The mechanism targets both physiological hunger signals and psychological food reward pathways, addressing multiple aspects of weight management simultaneously.
Streamlined Wegovy Ordering Process Despite Price Increase Pressures
EverydayMeds has maintained efficient prescribing services despite increased demand following the wegovy price increase affecting competitor availability. Our 3-minute online clinical assessment captures essential medical history and current medications, ensuring safe prescribing decisions. Qualified prescribers review applications within 3 working days (express 24-hour service available), with most approvals processed promptly for eligible patients. Once approved, all Wegovy pens are dispatched via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. This efficient process ensures patients can access their prescribed dose without delay, crucial for maintaining treatment schedules during dose escalation phases.
Proper Wegovy Storage and Administration Guidance
Wegovy requires refrigerated storage at 2-8°C before first use, though pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration. This flexibility provides significant travel advantages over some competitors, allowing extended trips without cooling requirements. The FlexTouch pen system delivers precise doses with a simple click mechanism, suitable for patients with limited dexterity. Each pen contains 4 doses of your prescribed strength, administered weekly on the same day. Dose escalation must follow the prescribed schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards.
Strategic Dose Planning Following Wegovy Price Increase
The wegovy price increase has made treatment planning more important than ever, with patients seeking cost-effective approaches to their 20-week escalation journey. EverydayMeds offers strategic bundle options that secure multiple doses in advance, protecting against future price volatility while ensuring Reliable Supply. Our Intro Trio bundle (0.25mg, 0.5mg, 1mg) covers the first 12 weeks for £299.99, providing price certainty during the crucial initial treatment phase.
For patients reaching maintenance therapy, the Ultimate Stability Trio (three 2.4mg pens) provides 12 weeks of treatment security for £649.99. This approach shields patients from potential future wegovy price increase impacts while guaranteeing access to their maintenance dose. Planning ahead becomes particularly valuable as dose escalation cannot be delayed without compromising treatment efficacy.
Securing Your Wegovy Supply at EverydayMeds
Don't let the wegovy price increase disrupt your weight management journey. EverydayMeds maintains comprehensive stock levels across all five Wegovy doses, backed by our GPhC registration (#9012878) and commitment to pharmaceutical excellence. New customers can apply code FIRST40 at checkout, while returning patients benefit from DOSE25 on subsequent orders. Our clinical team reviews applications promptly, with next-day delivery ensuring rapid access to your prescribed treatment. Start your Wegovy assessment today and secure reliable access to every dose throughout your treatment journey. Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
